Functional Anatomy of the Adaptive Immune Response Describe the principal functions of spleen, lymph nodes, tonsil Explain how lymphocytes get from the blood into a lymph node Describe the mechanism of dendritic cell antigen transport Understand how B cells encounter antigen Describe changes in effector T cells that permit migration to sites of inflammation Jason Cyster

Lymphatics One-way valves Lymph is filtered by Lymph Nodes before returning to circulation (liters per day) Lymph contains T and B cells and dendritic cells (thin walled)

capsule Cortex (T+B zone) medulla Primary follicles (B zones) germinal center (secondary follicle) Paracortex (T zone) mainly T-cells Anatomy of a Lymph Node medullary sinus subcapsular sinus radial sinus Filter antigens from the lymph - for recognition by T and B cells - for destruction by macrophages to prevent systemic spread

Spleen - A filter of the blood Two main functions of the spleen carried out in two major regions 1) White-pulp is where immune responses against blood-borne antigens occur 2) Red-pulp is responsible for monitoring and removing old or damaged RBC Red-pulp consists of thin walled splenic (or venous) sinuses and dense collections of blood cells (including numerous macrophages) that form red-pulp cords (or cords of Billroth) Blood supply: branches of central arteries open directly into red-pulp cords, adjacent to the splenic sinuses (open circulation) –Released RBC must cross the sinus walls; interendothelial slits are a major mechanical barrier and only the most supple, mechanically resilient RBC survive; old and damaged cells are removed by macrophages

Trabecular artery Trabecular vein Capsule Pulp vein Anatomy of the Spleen PALS or T zone (periarterial lymphoid sheath) Follicle (B zone) Red Pulp cord Splenic (venous) sinus White-Pulp cord

SECONDARY LYMPHOID ORGANS B cell follicle T cell zone red-pulp Splenic White-Pulp Cord Lymph Node Mucosal lymphoid tissue (e.g. Tonsil, Appendix) - filter antigens from body fluids - bring together antigen presenting cells and lymphocytes - help bring together antigen reactive B and T cells

Lymphocytes traverse HEVs to enter lymph nodes and then compartmentalize in B cell follicles and T cell zones LN section stained with: B cell marker L-selectin ligand T cell zone (paracortex) - T cells - DCs HEV (High Endothelial Venule) Follicle or B zone - B cells - FDCs

The cascade (multistep) model of leukocyte extravasation

lectins are sugar (carbohydrate)-binding proteins; selectins are a specialized type of lectin that bind appropriately glycosylated membrane proteins Three types: –L-selectin: restricted to lymphocytes ligands on lymphoid tissue HEVs –P-selectin: made by platelets and activated (inflammed) endothelium –E-selectin: made by activated (inflammed) endothelium E- and P-selectin ligands expressed on neutrophils, monocytes, activated T lymphocytes Selectins

>40, small secreted proteins Four families: C, CC, CXC, CX3C chemokine chemokine receptor Chemoattractant-Cytokines or “Chemokines” Cells with the appropriate receptor migrate (chemotax) up chemokine gradient Chemokines also promote cell adhesion to endothelium Lymphoid chemokines – help direct the homeostatic trafficking of cells through lymphoid tissues (e.g. CCR7 / CCL21; CXCR5 / CXCL13) Inflammatory chemokines – induced at sites of inflammation; can be expressed by many cell types; help recruit cells to these sites (e.g. CXCR2 / IL-8; CCR2/MCP1) outside cytoplasm

Integrins heterodimers of  and  polypeptide chains can be in inactive (low affinity for ligand) and active states intracellular signals can cause ‘inside-out’ signaling in the integrin, converting it from an inactive to an active state chemokine and antigen receptor signaling can activate integrins bind extracellular matrix proteins (e.g.  binds fibronectin) or transmembrane proteins (e.g. integrin LFA1 binds ICAM1; integrin  binds VCAM1) 

Cascade Model of Lymphocyte Recruitment into Lymph Nodes HEV STEP 1: Tethering and Rolling: L-Selectin- glycosylated HEV ligands STEP 2: Integrin Triggering: Chemokines (e.g. CCR7- CCL21) STEP 3: Firm Adherence: LFA1/ICAM1 STEP 4: Transmigration blood flow Lymphoid Tissue

Inhibitor of  integrin (tysabri) in clinical use for treatment of Multiple Sclerosis Multi-step cascade of lymphocyte migration to site of infection/inflammation: same logic, different ‘area code’

Schematic view of a lymph node CXCL13 CCL21 B zones produce a B cell attracting chemokine T zone produces T cell and DC attracting chemokines CXCL13 -> CXCR5 CCL21 -> CCR7 Follicle Paracortex Medulla

DCs migrate from periphery to lymphoid organ T zone bearing Ag immature ‘sentinel’ DCs are present in most tissues, continually sampling their microenvironment for antigen –by pinocytosis, phagocytosis and engulfment of apoptotic cells detection of ‘danger signals’ (e.g. LPS, dsRNA, bacterial DNA, necrotic cells, TNF, IL-1) causes the cells to mature –decrease adhesion to local tissue cells (e.g. keratinocytes) –increase expression of receptors (CCR7) for chemokines made by lymphatic endothelial cells and lymphoid organ T zones –upregulate MHC and costimulatory molecules migrate into lymphoid T zone present antigen to T cells

Immature (sentinel) DCs in tracheal epithelium longitudinal section tangential section

T zone Follicle DC Skin draining Lymph Node DCs migrate from periphery to lymphoid organ T zone bearing antigen LC = Langerhans’ Cell, the immature DC of the skin

lymph fluid hev B cell antigen encounter antigen FDC Sinus Macrophage B cells bind intact antigen through their surface Ig / B cell receptor (BCR) Antigen that enters via blood or lymph reaches the follicle and can be captured directly by B cells Follicular dendritic cells (FDCs – tissue resident cells related to fibroblasts) can display antigen on their surface in an intact form for long periods

Lymph node egress occurs in response to a circulatory lipid (sphingosine-1-phosphate, S1P) MEDULLARY SINUSES Diagram courtesy of Ted Yednock -Lymphocytes express a receptor (S1PR1) for S1P - Egress involves migrating to S1P that is high in blood/lymph and low in the tissue S1P

blood thymus, spleen S1PR1 S1P S1P lyase RBC efferent lymph lymph node, Peyer’s patch S1PR1 S1P S1P lyase Lymphocytes express S1PR1 and exit lymphoid organs in response to S1P S1PR1 is required for T cell egress from thymus and for T and B cell egress from spleen, lymph nodes, tonsil Activated lymphocytes transiently down-regulate S1PR1 and are retained in the responding lymphoid tissue until they become effectors FTY720 (Fingolimod) inhibits egress and is in clinical development as an immunosuppressant (FDA approved in 2010 for treatment of multiple sclerosis) FTY720 Immunosuppressant

Effector T cell Trafficking Activated T cells exit lymphoid tissue -> circulation –upregulate S1PR1 –ability to re-enter lymphoid tissue is reduced (decrease in CCR7, L-selectin) Increased ability to enter inflammed tissue due to increased expression of: –ligands for E- and P- selectins –receptors for inflammatory chemokines (e.g. CXCR3) –adhesion molecules (e.g. integrin  )